Circulation, Vol 61, 508-515, Copyright © 1980 by American Heart Association
KL Lee, JF McNeer, CF Starmer, PJ Harris and RA Rosati
A simulated randomized clinical trial in coronary artery disease was
conducted to illustrate the need for clinical judgment and modern
statistical methods in assessing therapeutic claims in studies of complex
diseases. Clinicians should be aware of problems that occur when a patient
sample is subdivided and treatment effects are assessed within multiple
prognostic categories. In this example, 1073 consecutive, medically treated
coronary artery disease patients from the Duke University data bank were
randomized into two groups. The groups were reasonably comparable and, as
expected, there was no overall difference in survival. In a subgroup of 397
patients characterized by three-vessel disease and an abnormal left
ventricular contraction, however, survival of group 1 patients was
significantly different from that of group 2 patients. Multivariable
adjustment procedures revealed that the difference resulted from the
combined effect of small imbalances in the distribution of several
prognostic factors. Another subgroup was identified in which a significant
survival difference was not explained by multivariable methods. These are
not unlikely examples in trials of a complex disease. Clinicians must
exercise careful judgment in attributing such results to an efficacious
therapy, as they may be due to chance or to inadequate baseline
comparability of the groups.
ARTICLES
Clinical judgment and statistics. Lessons from a simulated randomized trial in coronary artery disease
This article has been cited by other articles:
![]() |
V. Bansal, K. Hill, T. E. Dolmage, D. Brooks, L. J. Woon, and R. S. Goldstein Modifying Track Layout From Straight to Circular Has a Modest Effect on the 6-min Walk Distance Chest, May 1, 2008; 133(5): 1155 - 1160. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Ray Evidence in Upheaval: Incorporating Observational Data Into Clinical Practice Arch Intern Med, February 11, 2002; 162(3): 249 - 254. [Full Text] [PDF] |
||||
![]() |
E.-S. Han, T. R. Evans, S. Lee, and J. F. Nelson Food Restriction Differentially Affects Pituitary Hormone mRNAs throughout the Adult Life Span of Male F344 Rats J. Nutr., June 1, 2001; 131(6): 1687 - 1693. [Abstract] [Full Text] |
||||
![]() |
T. Treasure and K. D MacRae Minimisation is much better than the randomised block design in certain cases BMJ, May 22, 1999; 318(7195): 1420 - 1420. [Full Text] |
||||
![]() |
J M. Bland and D. G Altman Statistics notes: Multiple significance tests: the Bonferroni method BMJ, January 21, 1995; 310(6973): 170 - 170. [Full Text] [PDF] |
||||
![]() |
R. M. Califf, F. E. Harrell Jr, K. L. Lee, J. S. Rankin, M. A. Hlatky, D. B. Mark, R. H. Jones, L. H. Muhlbaier, H. N. Oldham Jr, and D. B. Pryor The Evolution of Medical and Surgical Therapy for Coronary Artery Disease: A 15-Year Perspective JAMA, April 14, 1989; 261(14): 2077 - 2086. [Abstract] [PDF] |
||||
![]() |
J. D. Abernethy The Need to Treat Mild Hypertension: Misinterpretation of Results From the Australian Trial JAMA, December 12, 1986; 256(22): 3134 - 3137. [Abstract] [PDF] |
||||
![]() |
T. Jonason and I. Ringqvist Mortality and Morbidity in Patients with Intermittent Claudication in Relation to the Location of the Occlusive Atherosclerosis in the Leg Angiology, May 1, 1985; 36(5): 310 - 314. [Abstract] [PDF] |
||||
![]() |
C. D. Furberg, E. Vittinghoff, M. Davidson, D. M. Herrington, J. A. Simon, N. K. Wenger, and S. Hulley Subgroup Interactions in the Heart and Estrogen/Progestin Replacement Study: Lessons Learned Circulation, February 26, 2002; 105(8): 917 - 922. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1980 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |